Lexicon Pharmaceuticals Inc (LXRX) can make a big difference with a little luck

With 2.04 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.83 million shares. The 52-week range on LXRX shows that it touched its highest point at $3.79 and its lowest point at $0.92 during that stretch. It currently has a 1-year price target of $6.25. Beta for the stock currently stands at 1.28.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LXRX was up-trending over the past week, with a rise of 4.25%, but this was down by -10.89% over a month. Three-month performance surged to 44.44% while six-month performance rose 102.75%. The stock lost -5.15% in the past year, while it has gained 44.44% so far this year. A look at the trailing 12-month EPS for LXRX yields -0.79 with Next year EPS estimates of -0.66. For the next quarter, that number is -0.20. This implies an EPS growth rate of 10.13% for this year and 7.51% for next year.

Float and Shares Shorts:

At present, 244.92 million LXRX shares are outstanding with a float of 239.51 million shares on hand for trading. On Mar 15, 2024, short shares totaled 21.35 million, which was 8.67% higher than short shares on Feb 15, 2024. In addition to RXRX as the firm’s Recursion Pharmaceuticals, Inc., LXRX serves as its Lexicon Pharmaceuticals, Inc.

Institutional Ownership:

Through their ownership of 82.16% of LXRX’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LXRX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, LXRX has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and LXRX currently yields $0.00. In the past year, LXRX’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, LXRX has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.